EntryPoint Capital, LLC
- SEC CIK
- 0001992519
- Latest filing
- Aug 13, 2026
CYTK holding history
Cytokinetics Inc in every 13F filed by EntryPoint Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CYTK overviewAll 13F holders of CYTKFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −6,586−100.0% | Sold out | Holders |
| Q2 2025 | 6,586 | $217.6K | 0.1% | −254−3.7% | Reduced | Holders |
| Q1 2025 | 6,840 | $274.9K | 0.1% | −4,083−37.4% | Reduced | Holders |
| Q4 2024 | 10,923 | $513.8K | 0.2% | +2,098+23.8% | Added | Holders |
| Q3 2024 | 8,825 | $466.0K | 0.3% | −314−3.4% | Reduced | Holders |
| Q2 2024 | 9,139 | $495.2K | 0.2% | +8,089+770.4% | Added | Holders |
| Q1 2024 | 1,050 | $73.6K | 0.1% | +1,050 | New | Holders |